Your browser doesn't support javascript.
loading
A Review of Brodalumab, an IL-17 Receptor Antagonist, for Moderate-to-Severe Plaque Psoriasis.
Tong, Y; Peranteau, A J; Nawas, Z; Tyring, S K.
  • Tong Y; Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, University of California San Diego, La Jolla, CA, USA.
  • Peranteau AJ; Center for Clinical Studies, Houston, TX, USA.
  • Nawas Z; Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Tyring SK; Center for Clinical Studies, Houston, TX, USA; Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Skin Therapy Lett ; 22(1): 1-6, 2017 Jan.
Article en En | MEDLINE | ID: mdl-28122092
Asunto(s)
Search on Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Receptores de Interleucina-17 / Anticuerpos Monoclonales Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article
Search on Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Receptores de Interleucina-17 / Anticuerpos Monoclonales Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article